Research with minors - Research with pregnant women and fetuses - Research with prisoners
Research with subjects who are not competent to provide consent - Research involving subjects with reproductive potential
Back to Contents
Research involving persons below the legal age of consent is important for the health and well-being of all children, and may be conducted by faculty, staff, and students of the UW provided the Human Subjects Review Committee (and where applicable, those of its affiliated institutions where such research will be performed), has determined that:
"Assent" in this context means the child's affirmative agreement to participate, not merely the absence of his or her objection, after adequate explanation. This differs from the term "consent," which indicates voluntary participation by a person of legal age and competency who is able to exercise free power of choice based on complete information. Assent must be obtained from any child who might reasonably be expected to comprehend the nature of his or her involvement in the research, regardless of age but at least by seven years. Research protocols should include forms for documentation of assent of subject children. Simplified written forms are recommended for children of seven years and over, and forms documenting oral assent for those under seven years or otherwise incapable of utilizing written forms.
The only exceptions to this requirement for assent of the child are: a) when the subject is incapable of comprehension or communication of understanding and assent or b) when the research intervention holds out a clear prospect of direct benefit that is important to the health or well-being of the child and is available only in the context of the research. In these cases, assent should not be offered. Under all other circumstances, a child's objection to participation in research shall be binding.
No research activity involving pregnant women as subjects may be conducted unless:
Research on pregnant women may be conducted only if the woman and the prospective father are legally competent and have given their informed consent after having been fully informed regarding possible impact on the fetus. The father's informed consent need not be secured if:
Research on fetuses in utero may be conducted if:
If a fetus ex utero has been found to be viable, it may not be involved as a subject unless:
A nonviable fetus may be involved as a subject in an activity covered by this subpart if:
Research involving prisoner subjects always requires Human Subjects Review Committee review, unless all of the information to be used by investigators is within the public domain. Research with prisoners that involves more than minimal risk has essentially been prohibited by Federal regulations.
Research involving prisoners is limited to the following areas:
Research may also be conducted on conditions particularly affecting prisoners as a class (for example, vaccine trials and other research on hepatitis, which is much more prevalent in prisons than elsewhere; and research on social and psychological problems such as alcoholism, drug addiction, and sexual assaults). The Human Subjects Review Committee will refer such applications to the Secretary of the Department of Health and Human Services. The study may proceed only after the Secretary has consulted with appropriate experts including experts in penology, medicine, and ethics, and published notice, in the Federal Register, of his intent to approve such research; or
Research on practices, both innovative and accepted, which have the intent and reasonable probability of improving the health or well-being of the subjects may also be conducted. If the study requires the assignment of prisoners to control groups that may not benefit from the research, the Human Subjects Review Committee will refer the application to the Secretary of the Department of Health and Human Services. The study may proceed only after the Secretary has consulted with appropriate experts, including experts in penology, medicine, and ethics, and published notice, in the Federal Register, of the intent to approve such research.
Any possible advantages accruing to the prisoner through his or her participation in the research, when compared to the general living conditions, medical care, quality of food, amenities and opportunity for earnings in the prison, may not be of such a magnitude that his or her ability to weigh the risks of the research against the value of such advantages in the limited choice environment of the prison is impaired.
The risks involved in the research should be commensurate with risks that would be accepted by non-prisoner volunteers.
Procedures for the selection of subjects within the prison must be fair to all prisoners and immune from arbitrary intervention by prison authorities or prisoners. Unless the principal investigator provides to the Human subjects Review Committee justification in writing for following some other procedures, control subjects must be selected randomly from the group of available prisoners who meet the characteristics needed for that particular research project.
The information about the study must be presented in language that is understandable to the subject population.
Adequate assurance must exist that parole boards will not take into account a prisoner's participation in the research in making decisions regarding parole, and each prisoner is clearly informed in advance that participation in the research will have no effect on his or her parole.
Where the Human Subjects Review Committee finds there may be a need for follow-up examination or care of participants after the end of their participation, adequate provision must be made for such examination or care, taking into account the varying lengths of individual prisoners' sentences, and for informing participants of this fact.
When the Human Subjects Review Committees review applications proposing to include prisoners as subjects, a prisoner advocate will be present for the deliberation.
When legal incompetents (other than children) and adults unable to give informed consent are to be used as subjects in diagnostic or therapeutic research, the legally responsible adult must sign the consent form giving approval for participation in the activity. Consent by the subject may be desirable, as well, but usually is optional. When neither diagnostic nor therapeutic procedures are involved, the legally incompetent's refusal to participate in non-therapeutic research is binding.
When there is a question about the competency of an adult who has not been declared legally incompetent, a subject advocate should participate in the consent process. The subject advocate should be able to attest to the subject's apparent understanding of the research or to the probable consent of the subject if he or she were competent. In this latter situation, the anticipated benefit to the subject should clearly outweigh the risks, if they are greater than minimal. Further, if there are any indications that he or she does not wish to participate, then the individual should be excluded from the study.
The subject advocate should be fully informed about the research and be a party, where possible, to the oral explanation given to the subject. The role of the subject advocate carries with it a shared responsibility for the welfare of the subject. Because of this responsibility, it may be desirable to involve the subject advocate, insofar as practicable, throughout the duration of the procedures or treatment.
The importance of the subject advocate increases with the risk to the subject. However, the subject advocate is intended as a protection and not as an obstacle in life-threatening situations where there are no alternative forms of treatment. Not all critically ill patients are "incompetent"; therefore an individual who has not been declared legally incompetent may choose to waive the right to a subject advocate by initialing the consent form where the subject advocate would otherwise sign. An investigator will want to consider such waivers very carefully.
It is important to conduct research to be able to detect the effects of gender, where relevant. Therefore, researchers should include equitable numbers of men and women as research subjects. Subjects with reproductive potential (women of childbearing potential and fertile men) should not be excluded from research unless the health of the subject or the integrity of the research would be placed at risk. The decision to enroll subjects of reproductive potential in studies should be made after evaluating the risks demonstrated in studies with appropriate animal subjects, the probably risks to humans, the nature of the disease under study, and the potential benefits of the study results.
Researchers must counsel subjects of reproductive age to use an active method of contraception or abstinence for as long as there is risk to a fetus. This use may extend beyond the termination of the study, in some cases. Female subjects of reproductive age should have a pregnancy test performed before beginning the study. Researchers may also perform pregnancy testing at intervals throughout the study depending on the nature of exposure to the intervention that poses risk to the fetus. When adolescents are involved in studies as subjects, researchers must take particular care to preserve the confidentiality of information about sexual activity and contraception use when discussing these issues with the adolescents' parents.
Consent forms used for studies in which there is potential risk to subjects of reproductive age should explain these risks in lay language and should also explain the need for use of contraception.